Skip to content

Clinical trials

Phase 3 Epilepsy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Phase: Phase 3 Country / region: United States Clear all

125 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20024
20031
20044
20056
20068
200710
200810
20092
20107
20119
20127
20134
20146
20158
20164
20174
20183
20193
20202
20215
20224
20233
20243
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed89
Terminated19
Recruiting8
Active, not recruiting3
Enrolling by invitation3
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB Pharma13
GlaxoSmithKline10
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.8
UCB BIOSCIENCES, Inc.8
Eisai Inc.6
Jazz Pharmaceuticals6
Xenon Pharmaceuticals Inc.6
Marinus Pharmaceuticals4
Sumitomo Pharma America, Inc.4
UCB Biopharma S.P.R.L.4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy125
Seizures60
Epilepsies, Partial20
Epilepsies, Myoclonic11
Lennox Gastaut Syndrome7
Brain Diseases6
Migraine Disorders4
Epilepsy, Absence3
Neurodevelopmental Disorders3
Central Nervous System Diseases2

Trials

Showing 1 to 25 of 125. Each trial links to its page on Pharma Observatory.

25 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.